Advertisement

Akutbehandlung des Ulcus duodeni und Ulcus ventriculi mit 40 mg Famotidin nocte — Ergebnisse einer offenen multizentrischen Studie

  • H. Schönekäs
Conference paper
  • 11 Downloads

Zusammenfassung

H2-Rezeptorantagonisten haben sich als die wirksamsten und am häufigsten angewandten Medikamente in der Behandlung des Ulcus pepticum erwiesen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Carratelli L. (im Druck): Clinical results with famotidine in Italy, Germany and Austria. International Workshop, Porto Cervo, June 2, 1984. Proceedings of the WorkshopGoogle Scholar
  2. 2.
    Dammann H G, Müller P, Simon B (1983): 24 hour intragastric acidity and single night-time dose of three H2-blockers. Lancet II: 1078CrossRefGoogle Scholar
  3. 3.
    Dammann H G, Barbara L, Bianchi Porro G, Cheli R, Hentschel E., Müller P, Paoluzi P, Simon B, Walter Th A (1985): Beschleunigte Heilung des Ulcus ventriculi unter einer abendlichen Einzeldosis von Famotidin. Schweiz med Wochenschr 115: 484–488PubMedGoogle Scholar
  4. 4.
    Dammann H G (1986): Einmal-am-Abendgabe von Famotidin. In: Simon B, Porro G, Dammann H G (Hrsg): Famotidin, Fortschritte in der Therapie säurebedingter Erkrankungen, Thieme, Stuttgart, SGoogle Scholar
  5. 5.
    Dawson J, Jain S, Cockel R (1984): Effect of ranitidine and Cimetidine on gastric ulcer healing and recurrence. Scand J. Gastroenterol 19: 665–668PubMedGoogle Scholar
  6. 6.
    Dickson B (im Druck): Cimetidine 800 mg once a day: preliminary European clinical data evaluation. Cimetidine today. International Workshop, Rome, March 14, 1984. Proceedings of the WorkshopGoogle Scholar
  7. 7.
    Dobrilla G, Granata F, Felder M, Piazzi L, Castelli G (1984): A single nocturnal does of ranitidine for the short-term treatment of uodenal ulcer. Interim results of an Italian multicentre study. In: Misiewicz J J, Wood J R: Ranitidine Therapeutic advances. Excerpta Medica, Amsterdam, pp 154–167Google Scholar
  8. 8.
    Dragstedt L R, Owens F M Jr (1943): Supradiaphragmatic section of vagus nervus in treatment of duodenal ulcer. Proc Soc Exp Biol 53: 152–154Google Scholar
  9. 9.
    Henning N, Norpoth I (1932): Die Magensekretion während des Schlafs. Dtsch Arch klin Med 172: 558Google Scholar
  10. 10.
    Howden C W et al. (1985): Nocturnal doses of H2-receptor antagonists for duodenal ulcer. Lancet I: 647CrossRefGoogle Scholar
  11. 11.
    Ireland A, Colin-Jones D G, Gear P, Golding P L et al. (1984): Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers. Lancet II: 274–276CrossRefGoogle Scholar
  12. 12.
    Mc Callum R W, Kulijan B, Chremos A N, Tupy-Visich M A et al (1983): Prolonged gastric antisecretory effect of a novel H2-receptor inhibitor, MK-208, Gastroenterology 84: A 1245Google Scholar
  13. 13.
    Rohner H G, Braun F J et al (1984): Cimetidine-Behandlung des Ulcus duodeni. Dtsch Med Wochenschr 109: 1087–1088PubMedGoogle Scholar
  14. 14.
    Takagi T, Takeda M, Maeno H (1982): Effect of a new potent H2-blocker (YM 1170) on gastric secretion, ulcer formation and weight of male accessory sex organs in rat. Arzneimittelforsch 32: 734–737PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • H. Schönekäs

There are no affiliations available

Personalised recommendations